The Drugs We Have and the Drugs We Need Against Major Helminth Infections

Advances in Parasitology

Volumn 73, Issue C, 2010, Pages 197-230

  Keiser, Jennifer ^a,b   Utzinger, Jürg ^a,b  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; ARTEMETHER; ARTEMISININ DERIVATIVE; ARTESUNATE; BENZIMIDAZOLE DERIVATIVE; BITHIONOL; CYCLOOCTADEPSIPEPTIDE DERIVATIVE; DIETHYLCARBAMAZINE; EMODEPSIDE; IVERMECTIN; LEVAMISOLE; MEBENDAZOLE; MEFLOQUINE; MONEPANTEL; NITAZOXANIDE; OXANTEL; OZ 78; OZ78; PRAZIQUANTEL; PROFENDER; PYRANTEL EMBONATE; TIABENDAZOLE; TRIBENDIMIDINE; TRICLABENDAZOLE; UNCLASSIFIED DRUG; ZOLVIX;

ASCARIASIS; ASCARIS LUMBRICOIDES; BOOK; CLONORCHIASIS; CLONORCHIS SINENSIS; DRUG MECHANISM; DRUG STRUCTURE; FASCIOLA; FASCIOLIASIS; HELMINTHIASIS; HOOKWORM INFECTION; INFECTION CONTROL; OPISTHORCHIASIS; OPISTHORCHIS; OPISTHORCHIS VIVERRINI; PARAGONIMIASIS; PARAGONIMUS; PRIORITY JOURNAL; SINGLE DRUG DOSE; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; TREMATODIASIS; TRICHURIASIS; TRICHURIS; ANIMAL; AUSTRALIA AND NEW ZEALAND; DRUG COMBINATION; DRUG DEVELOPMENT; DRUG EFFECTS; HELMINTH; HUMAN; PROCEDURES; SOUTHEAST ASIA; TRENDS;

ANIMALS; ANTHELMINTICS; ASIA, SOUTHEASTERN; AUSTRALASIA; COMMUNICABLE DISEASE CONTROL; DRUG DISCOVERY; DRUG THERAPY, COMBINATION; HELMINTHIASIS; HELMINTHS; HUMANS;

EID: 77954582391     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-308X(10)73008-6     Document Type: Chapter

References (154)

1. Adams V.J., Lombard C.J., Dhansay M.A., Markus M.B., Fincham J.E. Efficacy of albendazole against the whipworm Trichuris trichiura-a randomised, controlled trial. S. Afr. Med. J. 2004, 94:972-976.
2. Albonico M. Methods to sustain drug efficacy in helminth control programmes. Acta Trop. 2003, 86:233-242.
3. Albonico M., Bickle Q., Ramsan M., Montresor A., Savioli L., Taylor M. Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar. Bull. World Health Organ. 2003, 81:343-352.
4. Albonico M., Engels D., Savioli L. Monitoring drug efficacy and early detection of drug resistance in human soil-transmitted nematodes: a pressing public health agenda for helminth control. Int. J. Parasitol. 2004, 34:1205-1210.
5. Anonymous Drugs for parasitic infections. Med. Lett. 2007, 5:1-15.
6. Barnes E.H., Dobson R.J., Barger I.A. Worm control and anthelmintic resistance: adventures with a model. Parasitol. Today 1995, 11:56-63.
7. Beach M.J., Streit T.G., Addiss D.G., Prospere R., Roberts J.M., Lammie P.J. Assessment of combined ivermectin and albendazole for treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian schoolchildren. Am. J. Trop. Med. Hyg. 1999, 60:479-486.
8. Belizario V.Y., Amarillo M.E., de Leon W.U., de los Reyes A.E., Bugayong M.G., Macatangay B.J.C. A comparison of the efficacy of single doses of albendazole, ivermectin, and diethylcarbamazine alone or in combinations against Ascaris and Trichuris spp. Bull. World Health Organ. 2003, 81:35-42.
9. Benjapong W., Naeypatimanond S., Benjapong K., Thumaruksa C., Ruttarasarn S., Jaroonvesama N. Studies on paragonimiasis: treatment with mebendazole, emetine with mebendazole and praziquantel. Southeast Asian J. Trop. Med. Public Health 1984, 15:354-359.
10. Bergquist R., Johansen M.V., Utzinger J. Diagnostic dilemmas in helminthology: what tools to use and when?. Trends Parasitol. 2009, 25:151-156.
11. Bethony J., Brooker S., Albonico M., Geiger S.M., Loukas A., Diemert D., et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet 2006, 367:1521-1532.
12. Botero D., Castano A. Comparative study of pyrantel pamoate, bephenium hydroxynaphthoate, and tetrachloroethylene in the treatment of Necator americanus infections. Am. J. Trop. Med. Hyg. 1973, 22:45-52.
13. Bunnag D., Harinasuta T. Studies on the chemotherapy of Opisthorchis viverrini in Thailand. Clinical trial of praziquantel. Southeast Asian J. Trop. Med. Public Health 1980, 11:528-531.
14. Bunnag D., Radomyos P., Harinasuta T. Field trial on the treatment of fasciolopsiasis with praziquantel. Southeast Asian J. Trop. Med. Public Health 1983, 14:216-219.
15. Bunnag D., Pungpark S., Harinasuta T., Viravan C., Vanijanonta S., Suntharasamai P., et al. Opisthorchis viverrini: clinical experience with praziquantel in Hospital for Tropical Diseases. Arzneimittelforschung 1984, 34:1173-1174.
16. Cappello M., Bungiro R.D., Harrison L.M., Bischof L.J., Griffitts J.S., Barrows B.D., et al. A purified Bacillus thuringiensis crystal protein with therapeutic activity against the hookworm parasite Ancylostoma ceylanicum. Proc. Natl. Acad. Sci. USA 2006, 103:15154-15159.
17. Chai J.Y. Intestinal flukes. Food-Borne Parasitic Zoonoses 2007, 53-115. Springer, New York. K.D. Murrell, B. Fried (Eds.).
18. Chen C.Y., Hsieh W.C. Clonorchis sinensis: epidemiology in Taiwan and clinical experience with praziquantel. Arzneimittelforschung 1984, 34:1160-1162.
19. Coles G.C. Anthelmintic resistance and the control of worms. J. Med. Microbiol. 1999, 48:323-325.
20. Coles G.C. Drug resistance and drug tolerance in parasites. Trends Parasitol. 2006, 22:348.
21. Danso-Appiah A., Garner P., Olliaro P.L., Utzinger J. Treatment of urinary schistosomiasis: methodological issues and research needs identified through a Cochrane systematic review. Parasitology 2009, 136:1837-1849.
22. Datry A., Hilmarsdottir I., Mayorga-Sagastume R., Lyagoubi M., Gaxotte P., Biligui S., et al. Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases. Trans. R. Soc. Trop. Med. Hyg. 1994, 88:344-345.
23. Davison R.P. Evaluation of mebendazole for the treatment of trichuriasis. Med. J. Aust. 1979, 1:401-403.
24. De N.V., Cong L.D., Kino H., Son D.T., Vien H.V. Epidemiology, symptoms and treatment of paragonimiasis in Sin Ho district, Lai Chau province, Vietnam. Southeast Asian J. Trop. Med. Public Health 2000, 31(Suppl. 1):26-30.
25. de Silva N.R. Impact of mass chemotherapy on the morbidity due to soil-transmitted nematodes. Acta Trop. 2003, 86:197-214.
26. Doenhoff M.J., Cioli D., Utzinger J. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr. Opin. Infect. Dis. 2008, 21:659-667.
27. Fairweather I. Triclabendazole progress report, 2005-2009: an advancement of learning?. J. Helminthol. 2009, 83:139-150.
28. Favennec L., Jave Ortiz J., Gargala G., Lopez Chegne N., Ayoub A., Rossignol J.F., et al. Double-blind, randomized, placebo-controlled study of nitazoxanide in the treatment of fascioliasis in adults and children from northern Peru. Aliment. Pharmacol. Ther. 2003, 17:265-270.
29. Fox L.M., Furness B.W., Haser J.K., Desire D., Brissau J.M., Milord M.D., et al. Tolerance and efficacy of combined diethylcarbamazine and albendazole for treatment of Wuchereria bancrofti and intestinal helminth infections in Haitian children. Am. J. Trop. Med. Hyg. 2005, 73:115-121.
30. Gann P.H., Neva F.A., Gam A.A. A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J. Infect. Dis. 1994, 169:1076-1079.
31. Geary T.G., Woo K., McCarthy J.S., Mackenzie C.D., Horton J., Prichard R.K., et al. Unresolved issues in anthelmintic pharmacology for helminthiases of humans. Int. J. Parasitol. 2010, 40:1-13.
32. Geerts S., Gryseels B. Drug resistance in human helminths: current situation and lessons from livestock. Clin. Microbiol. Rev. 2000, 13:207-222.
33. Geerts S., Coles G.C., Gryseels B. Anthelmintic resistance in human helminths: learning from the problems with worm control in livestock. Parasitol. Today 1997, 13:149-151.
34. Grove D. A History of Human Helminthology 1990, CAB International, Wallingford.
35. Harder A., von Samson-Himmelstjerna G. Cyclooctadepsipeptides-a new class of anthelmintically active compounds. Parasitol. Res. 2002, 88:481-488.
36. Harder A., Schmitt-Wrede H.P., Krucken J., Marinovski P., Wunderlich F., Willson J., et al. Cyclooctadepsipeptides-an anthelmintically active class of compounds exhibiting a novel mode of action. Int. J. Antimicrob. Agents 2003, 22:318-331.
37. Harinasuta T., Bunnag D., Radomyos P. Efficacy of praziquantel on fasciolopsiasis. Arzneimittelforschung 1984, 34:1214-1215.
38. Hien T.T., Truong N.T., Minh N.H., Dat H.D., Dung N.T., Hue N.T., et al. A randomized controlled pilot study of artesunate versus triclabendazole for human fascioliasis in central Vietnam. Am. J. Trop. Med. Hyg. 2008, 78:388-392.
39. Horton J. Albendazole: a review of anthelmintic efficacy and safety in humans. Parasitology 2000, 121:S113-S132.
40. Hotez P.J., Ehrenberg J.P. Escalating the global fight against neglected tropical diseases through interventions in the Asia Pacific Region. Adv. Parasitol. 2010, 72:31-53.
41. Hotez P.J., Molyneux D.H., Fenwick A., Kumaresan J., Ehrlich Sachs S., Sachs J.D., et al. Control of neglected tropical diseases. N. Engl. J. Med. 2007, 357:1018-1027.
42. Hu Y., Xiao S.H., Aroian R.V. The new anthelmintic tribendimidine is an L-type (levamisole and pyrantel) nicotinic acetylcholine receptor agonist. PLoS Negl. Trop. Dis. 2009, 3:e499.
43. Hu Y., Georghiou S.B., Kelleher A.J., Aroian R.V. Bacillus thuringiensis Cry5B protein is highly efficacious as a single-dose therapy against an intestinal roundworm infection in mice. PLoS Negl. Trop. Dis. 2010, 4:e614.
44. Hu Y., Platzer E.G., Bellier A., Aroian R.V. Discovery of a highly synergistic anthelmintic combination that shows mutual hypersusceptibility. Proc. Nat. Acad. Sci. USA 2010, 107:5955-5960.
45. Hutchinson G.W., Dawson K., Fitzgibbon C.C., Martin P.J. Efficacy of an injectable combination anthelmintic (nitroxynil+clorsulon+ivermectin) against early immature Fasciola hepatica compared to triclabendazole combination flukicides given orally or topically to cattle. Vet. Parasitol. 2009, 162:278-284.
46. Igual-Adell R., Oltra-Alcaraz C., Soler-Company E., Sanchez-Sanchez P., Matogo-Oyana J., Rodriguez-Calabuig D. Efficacy and safety of ivermectin and thiabendazole in the treatment of strongyloidiasis. Expert Opin. Pharmacother. 2004, 5:2615-2619.
47. Imai J., Sakamoto O., Munthe F.E., Sinulingga S. Survey for soil-transmitted helminths in Asahan Regency, North Sumatra, Indonesia. Southeast Asian J. Trop. Med. Public Health 1985, 16:441-446.
48. Ismail M.M., Jayakody R.L. Efficacy of albendazole and its combinations with ivermectin or diethylcarbamazine (DEC) in the treatment of Trichuris trichiura infections in Sri Lanka. Ann. Trop. Med. Parasitol. 1999, 93:501-504.
49. James C.E., Hudson A.L., Davey M.W. Drug resistance mechanisms in helminths: is it survival of the fittest?. Trends Parasitol. 2009, 25:328-335.
50. Johansen M.V., Sithithaworn P., Bergquist R., Utzinger J. Towards improved diagnosis of zoonotic trematode infections in Southeast Asia. Adv. Parasitol. 2010, 73:171-195.
51. Kabil S.M., Ashry E.E., Ashraf N.K. An open-label clinical study of nitazoxanide in the treatment of human fascioliasis. Curr. Ther. Res. 2000, 61:339-345.
52. Kale O., Bammeke A.O., Nwankwo E.O. Field trials of pyrantel pamoate (Cobamtrin) in Ascaris, hookworm and Trichuris infection. Afr. J. Med. Sci. 1982, 11:23-31.
53. Kaminsky R., Ducray P., Jung M., Clover R., Rufener L., Bouvier J., et al. A new class of anthelmintics effective against drug-resistant nematodes. Nature 2008, 452:176-180.
54. Kaminsky R., Gauvry N., Schorderet Weber S., Skripsky T., Bouvier J., Wenger A., et al. Identification of the amino-acetonitrile derivative monepantel (AAD 1566) as a new anthelmintic drug development candidate. Parasitol. Res. 2008, 103:931-939.
55. Karadzovska D., Seewald W., Browning A., Smal M., Bouvier J., Giraudel J.M. Pharmacokinetics of monepantel and its sulfone metabolite, monepantel sulfone, after intravenous and oral administration in sheep. J. Vet. Pharmacol. Ther. 2009, 32:359-367.
56. Keiser J., Utzinger J. Chemotherapy for major food-borne trematodes: a review. Expert Opin. Pharmacother. 2004, 5:1711-1726.
57. Keiser J., Utzinger J. Advances in the discovery and development of novel trematocidal drugs. Expert Opin. Drug Discov. 2007, 2(Suppl. 1):9-23.
58. Keiser J., Utzinger J. Food-borne trematodiasis: current chemotherapy and advances with artemisinins and synthetic trioxolanes. Trends Parasitol. 2007, 23:555-562.
59. Keiser J., Utzinger J. Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. JAMA 2008, 299:1937-1948.
60. Keiser J., Utzinger J. Food-borne trematodiases. Clin. Microbiol. Rev. 2009, 22:466-483.
61. Keiser J., Engels D., Büscher G., Utzinger J. Triclabendazole for the treatment of fascioliasis and paragonimiasis. Expert Opin. Invest. Drugs 2005, 14:1513-1526.
62. Keiser J., Utzinger J., Tanner M., Dong Y., Vennerstrom J.L. The synthetic peroxide OZ78 is effective against Echinostoma caproni and Fasciola hepatica. J. Antimicrob. Chemother. 2006, 58:1193-1197.
63. Keiser J., Xiao S.H., Chollet J., Tanner M., Utzinger J. Evaluation of the in vivo activity of tribendimidine against Schistosoma mansoni, Fasciola hepatica, Clonorchis sinensis, and Opisthorchis viverrini. Antimicrob. Agents Chemother. 2007, 51:1096-1098.
64. Keiser J., Xiao S.H., Dong Y., Utzinger J., Vennerstrom J.L. Clonorchicidal properties of the synthetic trioxolane OZ78. J. Parasitol. 2007, 93:1208-1213.
65. Keiser J., Thiemann K., Endriss Y., Utzinger J. Strongyloides ratti: in vitro and in vivo activity of tribendimidine. PLoS Negl. Trop. Dis. 2008, 2:e201.
66. Keiser J., Chollet J., Xiao S.H., Mei J.Y., Jiao P.Y., Utzinger J., et al. Mefloquine-an aminoalcohol with promising antischistosomal properties in mice. PLoS Negl. Trop. Dis. 2009, 3:e350.
67. Keiser J., Odermatt P., Tesana S. Dose-response relationships and tegumental surface alterations in Opisthorchis viverrini following treatment with mefloquine in vivo and in vitro. Parasitol. Res. 2009, 105:261-266.
68. Keiser J., Xiao S.H., Smith T.A., Utzinger J. Combination chemotherapy against Clonorchis sinensis: experiments with artemether, artesunate, OZ78, praziquantel, and tribendimidine in a rat model. Antimicrob. Agents Chemother. 2009, 53:3770-3776.
69. Keiser J., Veneziano V., Rinaldi L., Mezzino L., Duthaler U., Cringoli G. Anthelmintic activity of artesunate against Fasciola hepatica in naturally infected sheep. Res. Vet. Sci. 2010, 88:107-110.
70. Kim J.S. Treatment of Paragonimus westermani infections with bithionol. Am. J. Trop. Med. Hyg. 1970, 19:940-942.
71. Kim T.I., Yoo W.G., Li S., Hong S.T., Keiser J., Hong S.J. Efficacy of artesunate and artemether against Clonorchis sinensis in rabbits. Parasitol. Res. 2009, 106:153-156.
72. Knopp S., Rinaldi L., Khamis I.S., Stothard J.R., Rollinson D., Maurelli M.P., et al. A single FLOTAC is more sensitive than triplicate Kato-Katz for the diagnosis of low-intensity soil-transmitted helminth infections. Trans. R. Soc. Trop. Med. Hyg. 2009, 103:347-354.
73. Lee S.H. Large scale treatment of Clonorchis sinensis infections with praziquantel under field conditions. Arzneimittelforschung 1984, 34:1227-1230.
74. Lv S., Zhang Y., Steinmann P., Zhou X.N., Utzinger J. Helminth infections of the central nervous system occurring in Southeast Asia and the Far East. Adv. Parasitol. 2010, 72:351-408.
75. Malhotra B.K., Wood N., Sachse R. Influence of age, gender, and race on pharmacokinetics, pharmacodynamics, and safety of fesoterodine. Int. J. Clin. Pharmacol. Ther. 2009, 47:570-578.
76. Malikides N., Spencer K., Mahoney R., Baker K., Vanhoff K., Hall C., et al. Safety of an amino-acetonitrile derivative (AAD), monepantel, in ewes and their offspring following repeated oral administration. N. Z. Vet. J. 2009, 57:193-202.
77. Mani T.R., Rajendran R., Munirathinam A., Sunish I.P., Abdullah S.M., Augustin D.J., et al. Efficacy of co-administration of albendazole and diethylcarbamazine against geohelminthiases: a study from South India. Trop. Med. Int. Health 2002, 7:541-548.
78. Marti H., Haji H.J., Savioli L., Chwaya H.M., Mgeni A.F., Ameir J.S., et al. A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. Am. J. Trop. Med. Hyg. 1996, 55:477-481.
79. Moncayo A.L., Vaca M., Amorim L., Rodriguez A., Erazo S., Oviedo G., et al. Impact of long-term treatment with ivermectin on the prevalence and intensity of soil-transmitted helminth infections. PLoS Negl. Trop. Dis. 2008, 2:e293.
80. Moran M. A breakthrough in R&D for neglected diseases: new ways to get the drugs we need. PLoS Med. 2005, 2:e302.
81. Moulia-Pelat J.P., Nguyen L.N., Hascoet H., Luquiaud P., Nicolas L. Advantages of an annual single dose of ivermectin 400 micrograms/kg plus diethylcarbamazine for community treatment of bancroftian filariasis. Trans. R. Soc. Trop. Med. Hyg. 1995, 89:682-685.
82. Na-Bangchang K., Kietinun S., Pawa K.K., Hanpitakpong W., Na-Bangchang C., Lazdins J. Assessments of pharmacokinetic drug interactions and tolerability of albendazole, praziquantel and ivermectin combinations. Trans. R. Soc. Trop. Med. Hyg. 2006, 100:335-345.
83. Nahmias J., Kennet R., Goldsmith R., Greenberg Z. Evaluation of albendazole, pyrantel, bephenium, pyrantel-praziquantel and pyrantel-bephenium for single-dose mass treatment of necatoriasis. Ann. Trop. Med. Parasitol. 1989, 83:625-629.
84. Ndyomugyenyi R., Kabatereine N., Olsen A., Magnussen P. Efficacy of ivermectin and albendazole alone and in combination for treatment of soil-transmitted helminths in pregnancy and adverse events: a randomized open label controlled intervention trial in Masindi district, western Uganda. Am. J. Trop. Med. Hyg. 2008, 79:856-863.
85. Okelo G.B.A. Open and placebo-controlled studies of albendazole in the treatment of intestinal helminthiasis. R. Soc. Med. Int. Congr. Symp. Ser. 1984, 61:57-62.
86. Olds G.R., King C., Hewlett J., Olveda R., Wu G., Ouma J., et al. Double-blind placebo-controlled study of concurrent administration of albendazole and praziquantel in schoolchildren with schistosomiasis and geohelminths. J. Infect. Dis. 1999, 179:996-1003.
87. Olsen A. Efficacy and safety of drug combinations in the treatment of schistosomiasis, soil-transmitted helminthiasis, lymphatic filariasis and onchocerciasis. Trans. R. Soc. Trop. Med. Hyg. 2007, 76:732-736.
88. Ordonez L.E., Angulo E.S. Efficacy of ivermectin in the treatment of children parasitized by Strongyloides stercoralis. Biomedica 2004, 24:33-41.
89. Ottesen E.A., Duke B.O.L., Karam M., Behbehani K. Strategies and tools for the control/elimination of lymphatic filariasis. Bull. World Health Organ. 1997, 75:491-503.
90. Pécoul B., Chirac P., Trouiller P., Pinel J. Access to essential drugs in poor countries: a lost battle?. JAMA 1999, 281:361-367.
91. Pungpak S., Bunnag D., Harinasuta T. Clinical and laboratory evaluation of praziquantel in opisthorchiasis. Southeast Asian J. Trop. Med. Public Health 1983, 14:363-366.
92. Pungpak S., Chalermrut K., Harinasuta T., Viravan C., Schelp P.F., Hempfling A., et al. Opisthorchis viverrini infection in Thailand: symptoms and signs of infection-a population-based study. Trans. R. Soc. Trop. Med. Hyg. 1994, 88:561-564.
93. Pungpak S., Viravan C., Radomyos B., Chalermrut K., Yemput C., Plooksawasdi W., et al. Opisthorchis viverrini infection in Thailand: studies on the morbidity of the infection and resolution following praziquantel treatment. Am. J. Trop. Med. Hyg. 1997, 56:311-314.
94. Pungpak S., Radomyos P., Radomyos B.E., Schelp F.P., Jongsuksuntigul P., Bunnag D. Treatment of Opisthorchis viverrini and intestinal fluke infections with praziquantel. Southeast Asian J. Trop. Med. Public Health 1998, 29:246-249.
95. Rabbani G.H., Gilman R.H., Kabir I., Mondel G. The treatment of Fasciolopsis buski infection in children: a comparison of thiabendazole, mebendazole, levamisole, pyrantel pamoate, hexylresorcinol and tetrachloroethylene. Trans. R. Soc. Trop. Med. Hyg. 1985, 79:513-515.
96. Rim H.J. Paragonimiasis: experimental and clinical experience with praziquantel in Korea. Arzneimittelforschung 1984, 34:1197-1203.
97. Rim H.J., Lyu K.S., Lee J.S., Joo K.H. Clinical evaluation of the therapeutic efficacy of praziquantel (Embay 8440) against Clonorchis sinensis infection in man. Ann. Trop. Med. Parasitol. 1981, 75:27-33.
98. Rim H.J., Lee Y.M., Lee J.S., Joo K.H. Therapeutic field trial with praziquantel (Biltricide(R)) in a rural population infected with Clonorchis sinensis. Kisaengchunghak Chapchi 1982, 20:1-8.
99. Sargent R.G., Dotterer T.D., Savory A.M., Lee P.R. A clinical evaluation of the efficacy of mebendazole in the treatment of trichuriasis. South. Med. J. 1975, 68:38-40.
100. Satoh M., Kokaze A. Treatment strategies in controlling strongyloidiasis. Expert Opin. Pharmacother. 2004, 5:2293-2301.
101. Savioli L., Gabrielli A.F., Montresor A., Chitsulo L., Engels D. Schistosomiasis control in Africa: 8 years after World Health Assembly Resolution 54.19. Parasitology 2009, 136:1677-1681.
102. Schratz A., Fernanda Pineda M., Reforma L.G., Fox N.M., Anh T.L., Cavalli-Sforza L.T., et al. Neglected diseases and ethnic minorities in the Western Pacific Region: exploring the links. Adv. Parasitol. 2010, 72:79-107.
103. Schwenkenbecher J.M., Albonico M., Bickle Q., Kaplan R.M. Characterization of beta-tubulin genes in hookworms and investigation of resistance-associated mutations using real-time PCR. Mol. Biochem. Parasitol. 2007, 156:167-174.
104. Seah S.K. Pyrantel pamoate in treatment of helminthiasis in a non-endemic area. Southeast Asian J. Trop. Med. Public Health 1973, 4:534-542.
105. Seubert J., Pohlke R., Loebich F. Synthesis and properties of praziquantel, a novel broad spectrum anthelmintic with excellent activity against schistosomes and cestodes. Experientia 1977, 33:1036-1037.
106. Sheps J.A., Ling V. Preface: the concept and consequences of multidrug resistance. Pflugers Arch. 2007, 453:545-553.
107. Shey M., Kongnyuy E.J., Shang J., Wiysonge C.S. A combination drug of abacavir-lamivudine-zidovudine (Trizivir) for treating HIV infection and AIDS. Cochrane Database Syst. Rev. 2009, CD005481.
108. Shield J. A study of the effectiveness of mebendazole and pyrantel pamoate as a combination anthelmintic in Papua New Guinean children. P. N. G. Med. J. 1985, 28:41-44.
109. Shikiya K., Kuniyoshi T., Higashionna A., Arakkaki T., Oyakawa T., Kadena K., et al. Treatment of strongyloidiasis with mebendazole and its combination with thiabendazole. Kansenshogaku Zasshi 1990, 64:1408-1415.
110. Shikiya K., Kinjo N., Ikema M., Yamashiro A., Uechi H., Oyakawa T., et al. Comparison of efficacy of powder and tablet of mebendazole in the treatment of strongyloidiasis. Kansenshogaku Zasshi 1991, 65:681-686.
111. Shikiya K., Uehara T., Uechi H., Ohshiro J., Arakaki T., Oyakawa T., et al. Clinical study on ivermectin against Strongyloides stercoralis. Kansenshogaku Zasshi 1991, 65:1085-1090.
112. Shikiya K., Kinjo N., Uehara T., Uechi H., Ohshiro J., Arakaki T., et al. Efficacy of ivermectin against Strongyloides stercoralis in humans. Intern. Med. 1992, 31:310-312.
113. Sinniah B., Sinniah D., Dissanaike A.S. Single dose treatment of intestinal nematodes with oxantel-pyrantel pamoate plus mebendazole. Ann. Trop. Med. Parasitol. 1980, 74:619-623.
114. Sirivichayakul C., Pojjaroen-anant C., Wisetsing P., Chanthavanich P., Praevanit R., Limkittikul K., et al. A comparative trial of albendazole alone versus combination of albendazole and praziquantel for treatment of Trichuris trichiura infection. Southeast Asian J. Trop. Med. Public Health 2001, 32:297-301.
115. Smits H.L. Prospects for the control of neglected tropical diseases by mass drug administration. Expert Rev. Anti. Infect. Ther. 2009, 7:37-56.
116. Soh C.T. Clonorchis sinensis: experimental and clinical studies with praziquantel in Korea. Arzneimittelforschung 1984, 34:1156-1159.
117. Sornmani S., Schelp F.P., Vivatanasesth P., Patihatakorn W., Impand P., Sitabutra P., et al. A pilot project for controlling O. viverrini infection in Nong Wai, Northeast Thailand, by applying praziquantel and other measures. Arzneimittelforschung 1984, 34:1231-1234.
118. Sripa B., Kaewkes S., Intapan P.M., Maleewong W., Brindley P.J. Food-borne trematodiases in Southeast Asia: epidemiology, pathology, clinical manifestation and control. Adv. Parasitol. 2010, 72:305-350.
119. Steinmann P., Zhou X.N., Du Z.W., Jiang J.Y., Xiao S.H., Wu Z.X., et al. Tribendimidine and albendazole for treating soil-transmitted helminths, Strongyloides stercoralis and Taenia spp.: open-label randomized trial. PLoS Negl. Trop. Dis. 2008, 2:e322.
120. Steinmann P., Utzinger J., Du Z.W., Zhou X.N. Multiparasitism: a neglected reality on global, regional and local scale. Adv. Parasitol. 2010, 73:21-50.
121. Stevenson C.R., Mahoney R.H., Fisara P., Strehlau G., Reichel M.P. The efficacy of formulations of triclabendazole and ivermectin in combination against liver fluke (Fasciola hepatica) and gastro-intestinal nematodes in cattle and sheep and sucking lice species in cattle. Aust. Vet. J. 2002, 80:698-701.
122. Stoll N.R. This wormy world. J. Parasitol. 1947, 33:1-18.
123. Sudomo M., Chayabejara S., Duong S., Hernandez L., Wu W.P., Bergquist R. Elimination of lymphatic filariasis in Southeast Asia. Adv. Parasitol. 2010, 72:205-233.
124. Tinga N., De N., Vien H.V., Chau L., Toan N.D., Kager P.A., et al. Little effect of praziquantel or artemisinin on clonorchiasis in Northern Vietnam. A pilot study. Trop. Med. Int. Health 1999, 4:814-818.
125. Trouiller P., Olliaro P., Torreele E., Orbinski J., Laing R., Ford N. Drug development for neglected diseases: a deficient market and a public-health policy failure. Lancet 2002, 359:2188-2194.
126. Udonsi J.K. Clinical field trials of praziquantel in pulmonary paragonimiasis due to Paragonimus uterobilateralis in endemic populations of the Igwun Basin, Nigeria. Trop. Med. Parasitol. 1989, 40:65-68.
127. Upatham E.S., Viyanant V., Brockelman W.Y., Kurathong S., Lee P., Kraengraeng R. Rate of re-infection by Opisthorchis viverrini in an endemic northeast Thai community after chemotherapy. Int. J. Parasitol. 1988, 18:643-649.
128. Utzinger J., Keiser J. Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control. Expert Opin. Pharmacother. 2004, 5:263-285.
129. Utzinger J., Keiser J., Xiao S.H., Tanner M., Singer B.H. Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrob. Agents Chemother. 2003, 47:1487-1495.
130. Utzinger J., Xiao S.H., Tanner M., Keiser J. Artemisinins for schistosomiasis and beyond. Curr. Opin. Invest. Drugs 2007, 8:105-116.
131. van den Enden E. Pharmacotherapy of helminth infection. Expert Opin. Pharmacother. 2009, 10:435-451.
132. Vandepitte J., Gatti F., Lontie M., Krubwa F., Nguete K., Thienpont D. Mebendazole, new broad spectrum anthelminthic agent against trichocephalosis. Bull. Soc. Pathol. Exot. Filiales 1973, 66:165-178.
133. Vanijanonta S., Bunnag D., Harinasuta T. Paragonimus heterotremus and other Paragonimus spp. in Thailand: pathogenesis, clinic and treatment. Arzneimittelforschung 1984, 34:1186-1188.
134. Viravan C., Bunnag D., Harinasuta T., Upatham S., Kurathong S., Viyanant V. Clinical field trial of praziquantel in opisthorchiasis in Nong Rangya village, Khon Kaen province, Thailand. Southeast Asian J. Trop. Med. Public Health 1986, 17:63-66.
135. von Samson-Himmelstjerna G., Harder A., Sangster N.C., Coles G.C. Efficacy of two cyclooctadepsipeptides, PF1022A and emodepside, against anthelmintic-resistant nematodes in sheep and cattle. Parasitology 2005, 130:343-347.
136. Wegner D.H. The profile of the trematodicidal compound praziquantel. Arzneimittelforschung 1984, 34:1132-1136.
137. Wen L.Y., Yan X.L., Sun F.H., Fang Y.Y., Yang M.J., Lou L.J. A randomized, double-blind, multicenter clinical trial on the efficacy of ivermectin against intestinal nematode infections in China. Acta Trop. 2008, 106:190-194.
138. Wesche D., Barnish G. A comparative study of the effectiveness of mebendazole (Janssen) and generically equivalent mebendazole (Nordia) in intestinal helminthiasis in Papua New Guinean children. P. N. G. Med. J. 1994, 37:7-11.
139. White N. Antimalarial drug resistance and combination chemotherapy. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1999, 354:739-749.
140. The control of schistosomiasis: report of a WHO expert committee. WHO Tech. Rep. Ser. No. 728 1985, WHO.
141. Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a WHO expert committee. WHO Tech. Rep. Ser. No. 912 2002, WHO.
142. Preventive chemotherapy in human helminthiasis: coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers 2006, WHO, World Health Organization, Geneva.
143. Soil-transmitted helminthiasis. Wkly. Epidemiol. Rec. 2008, 83:237-252. WHO.
144. WHO Model Formulary 2008 2009, WHO, World Health Organization, Geneva. M.C. Stuart, M. Kouimtzi, R.S. Hill (Eds.).
145. Williams L., Hill D.P., Davis J.A., Lowenthal D.T. The influence of food on the absorption and metabolism of drugs: an update. Eur. J. Drug Metab. Pharmacokinet. 1996, 21:201-211.
146. Willingham, III A.L., Wu H.W., Coulan J., Satrija F. Combating Tania solium cysticerosis in Southeast Asia: an opportunity for improving human health and livestock production. Adv. Parasitol. 2010, 72:235-266.
147. Xiao S.H., Wu H.M., Tanner M., Utzinger J., Chong W. Tribendimidine: a promising, safe and broad-spectrum anthelmintic agent from China. Acta Trop. 2005, 94:1-14.
148. Xiao S.H., Wu Z.X., Zhang J.H., Wang S.Q., Wang S.H., Qiu D.C., et al. Clinical observation on 899 children infected with intestinal nematodes and treated with tribendimidine enteric coated tablets. Chin. J. Parasitol. Parasit. Dis. 2007, 25:372-375.
149. Xiao S.H., Keiser J., Chen M.G., Tanner M., Utzinger J. Research and development of antischistosomal drugs in the People's Republic of China: a 60-year review. Adv. Parasitol. 2010, 73:231-295.
150. Zavoikin V.D., Zelia O.P., Bronshtein A.M., Sokerina O.A., Iarotskii L.S., Firsova R.A., et al. The procedure for the wide use of praziquantel in a complex of measures to control opisthorchiasis. 1. The tolerance and efficacy of different doses of biltricide during outpatient use in foci. Med. Parazitol. (Mosk) 1994, 3:24-27.
151. Zhang Y. Advances in the treatment of tuberculosis. Clin. Pharmacol. Ther. 2007, 82:595-600.
152. Zhang X.R., Yang W.J., Yang C., Liao Z.Y., Liu Y.M., Tang Z.J., et al. Effect of albendazole and pyrantel in treating intestinal helminthiasis and controlling the recurrence of hookworm infections. Chin. J. Parasitol. Parasit. Dis. 1990, 8:96-99.
153. Zhang D., Zhang X., Tang Z., Chen C., Chen Y., Yang W., et al. Field trials on the efficacy of albendazole composite against intestinal nematodiasis. Chin. J. Parasitol. Parasit. Dis. 1998, 16:1-5.
154. Zhang J.H., Xiao S.H., Wu Z.X., Qiu D.C., Wang S.H., Wang S.Q., et al. Tribendimidine enteric coated tablet in treatment of 1,292 cases with intestinal nematode infection-a phase IV clinical trial. Chin. J. Parasitol. Parasit. Dis. 2008, 26:6-9.